Search results for " thyroid cancer"

showing 10 items of 38 documents

The New TNM Staging System for Thyroid Cancer and the Risk of Disease Downstaging

2018

In October 2016 the American Joint Committee on Cancer (AJCC) published the 8th edition of the AJCC/TNM cancer staging system and it has been introduced in clinical practice since 1st January 2018. The effect of most of the changes in the new edition was the downstaging of a significant number of patients into lower stages, reflecting their low risk of thyroid cancer-related death. One of the most relevant modification refers to the role of the microscopic extra-thyroidal tumor invasion, which is no longer considered as criterion for the classification of T3 tumors. With the present study we want to assess the impact of the changes of the new staging system and therefore we analyzed or casi…

Oncologymedicine.medical_specialtyEndocrinology Diabetes and MetabolismDownstaging; Staging system; Thyroid cancer; TNM 2018; Tumor invasion; Endocrinology Diabetes and Metabolism030209 endocrinology & metabolismAggressive diseaseDiseaseTNM staging systemlcsh:Diseases of the endocrine glands. Clinical endocrinology03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicinethyroid cancerstaging systemMedicineStaging systemThyroid cancerCancer stagingOriginal Researchlcsh:RC648-665TNM 2018business.industryThyroidCancerdownstagingtumor invasionmedicine.diseaseDiabetes and Metabolismmedicine.anatomical_structure030220 oncology & carcinogenesisbusinessFrontiers in Endocrinology
researchProduct

Anaplastic Thyroid Cancer in Sicily: The Role of Environmental Characteristics

2017

Background: Anaplastic thyroid cancer (ATC) is a rare but extremely aggressive cancer of the thyroid, contributing up to 30-40% of thyroid cancer-specific mortality. We analyzed ATC characteristics and survival rates in Sicily to evaluate the possible influence of environmental factors. With this aim data regarding ATC incidences in urban/rural and industrial, iodine deficient and volcanic vs. control areas were compared in Sicily as well as ATC data from Sicily and USA. Methods: Using the Sicilian Register of Thyroid Cancer (SRTC) database incidence, age, gender, tumor size and histotype, extrathyroidal extension, stage and coexistence with pre-existing differentiated thyroid cancer (DTC) …

Pathologymedicine.medical_specialtyMultivariate analysisThyroid Cancer Registrythyroid cancer and volcanic environmentEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismlcsh:Diseases of the endocrine glands. Clinical endocrinologyPapillary thyroid cancer03 medical and health sciences0302 clinical medicineEndocrinologySurveillance Epidemiology and End Resultsthyroid cancerMedicineAnaplastic thyroid cancerThyroid cancerthyroid cancer epidemiologyOriginal ResearchUnivariate analysislcsh:RC648-665business.industryIncidence (epidemiology)Thyroidmedicine.diseaseDiabetes and Metabolismmedicine.anatomical_structure030220 oncology & carcinogenesisAnaplastic thyroid cancer; Thyroid cancer; Thyroid cancer and volcanic environment; Thyroid cancer epidemiology; Thyroid Cancer Registry; Endocrinology Diabetes and MetabolismbusinessDemographyanaplastic thyroid cancerFrontiers in Endocrinology
researchProduct

Multiple Pluripotent Stem Cell Markers in Human Anaplastic Thyroid Cancer: The Putative Upstream Role of SOX2

2013

Anaplastic thyroid carcinoma (ATC) is a rare and aggressive endocrine tumor with highly undifferentiated morphology. It has been suggested that cancer stem cells (CSCs) might play a central role in ATC. The objectives of this study were (i) to characterize CSCs from ex vivo ATC specimens by investigating the expression of several pluripotent stem cell markers, and (ii) to evaluate in vitro drug resistance modifications after specific CSC transcription factor switch-off.In ex vivo experiments, eight formalin-fixed, paraffin-embedded ATC specimens were analyzed by reverse-transcription and real-time quantitative PCR and immunohistochemistry. In in vitro experiments using ATC SW1736 cells, the…

Pluripotent Stem Cellscongenital hereditary and neonatal diseases and abnormalitiesEndocrinology Diabetes and MetabolismDown-RegulationBiologyThyroid Carcinoma AnaplasticAnaplastic thyroid cancer cancer stem cell SOX-2Settore MED/13 - EndocrinologiaThyroid carcinomaKruppel-Like Factor 4EndocrinologySOX2Cancer stem cellCell Line TumormedicineATP Binding Cassette Transporter Subfamily G Member 2HumansNeoplasmThyroid NeoplasmsAnaplastic thyroid cancerInduced pluripotent stem cellHomeodomain ProteinsSOXB1 Transcription FactorsNanog Homeobox ProteinNanog Homeobox ProteinThyroid Cancer and Nodulesmedicine.diseaseNeoplasm ProteinsUp-RegulationDoxorubicinDrug Resistance NeoplasmCell cultureNeoplastic Stem CellsCancer researchATP-Binding Cassette TransportersCisplatinOctamer Transcription Factor-3Thyroid
researchProduct

Differential proteomic and phenotypic behaviour of papillary and anaplastic thyroid cell lines.

2013

Abstract Thyroid carcinomas account for a minority of all malignant tumours but, after those of the gonads, they represent the most common forms of endocrine cancers. They include several types, among which the papillary thyroid cancer (PTC) and the anaplastic thyroid cancer (ATC) are the best known. The two hystotypes display significant biological and clinical differences: PTC is a well differentiated form of tumour with a high incidence and a good prognosis, while the ATC is less frequent but represents one of the most aggressive endocrine tumours with morphological features of an undifferentiated type. To date, as far as we know, no conclusive studies, useful to design arrays of molecul…

ProteomicsProteomeendocrine system diseasesProtein Array AnalysisBiophysicsBiologythyroid cell linesThyroid Carcinoma AnaplasticProteomicsBiochemistryPapillary thyroid cancerThyroid carcinomaCell MovementCell Line TumorBiomarkers TumormedicineHumansEndocrine systemThyroid NeoplasmsAnaplastic thyroid cancerThyroid cancerCell ProliferationCarcinomamedicine.diseasePhenotypeCarcinoma PapillaryNeoplasm ProteinsThyroid Cancer PapillaryImmunologyProteomeCancer research
researchProduct

Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5

2017

Background: Incidence rates of thyroid cancer (TC) increased in several countries during the last 30 years, while mortality rates remained unchanged, raising important questions for treatment and follow-up of TC patients. This study updates population-based estimates of relative survival (RS) after TC diagnosis in Europe by sex, country, age, period and histology.Methods: Data from 87 cancer registries in 29 countries were extracted from the EUROCARE-5 dataset. One-and 5-year RS were estimated using the cohort approach for 86,690 adult TC patients diagnosed in 2000-2007 and followed-up to 12/31/2008. RS trends in 1999-2007 and 10-year RS in 2005-2007 were estimated using the period approach…

RegistrieMaleCancer ResearchIMPACTCancer registrie[SDV]Life Sciences [q-bio]Papillary0302 clinical medicineQUALITY-OF-LIFEResidence CharacteristicsAdenocarcinoma FollicularCancer registriesRegistriesThyroid cancerThyroid Neoplasmeducation.field_of_studyRelative survivalIncidence (epidemiology)Mortality rateIncidenceDiagnosis-Related GroupCancer registries; EUROCARE; Europe; Papillary; Relative survival; Thyroid cancer; Adenocarcinoma Follicular; Adolescent; Adult; Aged; Carcinoma; Carcinoma Papillary; Diagnosis-Related Groups; Europe; Female; Humans; Incidence; Male; Middle Aged; Registries; Residence Characteristics; Sex Distribution; Thyroid Neoplasms; Young Adult; Oncology; Cancer ResearchMiddle AgedPREVALENCE3. Good healthEuropeOncologyThyroid Cancer Papillary030220 oncology & carcinogenesisCohortFemaleEUROCAREHumanAdultmedicine.medical_specialtyAdolescentPopulationGEOGRAPHICAL-DISTRIBUTIONUNITED-STATESSocio-culturale030209 endocrinology & metabolismAdenocarcinomaRelative survivalThyroid cancerRECENT TRENDS03 medical and health sciencesYoung AdultMANAGEMENTmedicineHumansThyroid NeoplasmsSex DistributioneducationSurvival rateDiagnosis-Related GroupsAgedbusiness.industryMORTALITYCarcinomaFollicularCancer registries; EUROCARE; Europe; Papillary; Relative survival; Thyroid cancer; Oncology; Cancer Researchmedicine.diseaseCarcinoma PapillaryCancer registrySurgeryMICROCARCINOMAResidence CharacteristicCancer registries ; EUROCARE ; Europe ; Papillary ; Relative survival ; Thyroid cancerbusinessDemography
researchProduct

Suppressor of cytokine signaling 3 sensitizes anaplastic thyroid cancer to standard chemotherapy

2009

We previously showed that cancer cells from papillary, follicular, and anaplastic thyroid carcinomas produce interleukin-4 and interleukin-10, which counteract the cytotoxic activity of conventional chemotherapy through the up-regulation of antiapoptotic molecules. Here, we identify Janus kinase/signal transducers and activators of transcription (STAT) and phosphatidyl inositol 3-kinase (PI3K)/AKT as the down-stream pathways through which these cytokines confer resistance to cell death in thyroid cancer. We found that the absence of suppressors of cytokine signaling (SOCS) molecules allows the propagation of the survival signaling. Exogenous expression of SOCS1, SOCS3, and SOCS5 in the high…

STAT3 Transcription FactorCancer ResearchCancer Research; OncologyDown-RegulationMice NudeSuppressor of Cytokine Signaling Proteinsthyroidcancer spheres cytokines apoptosis chemoterapyMicePhosphatidylinositol 3-KinasesSuppressor of Cytokine Signaling 1 ProteinMedicineAnimalsHumansSOCS3Thyroid NeoplasmsAnaplastic thyroid cancerPhosphorylationThyroid cancerPI3K/AKT/mTOR pathwayAgedSettore MED/04 - Patologia GeneraleJanus kinase 1business.industrySuppressor of cytokine signaling 1Settore BIO/16 - Anatomia UmanaGene Transfer TechniquesCancerJanus Kinase 1Middle Agedmedicine.diseaseXenograft Model Antitumor AssaysSettore MED/18 - Chirurgia GeneraleOncologyDrug Resistance NeoplasmSuppressor of Cytokine Signaling 3 ProteinImmunologyCancer researchFemalebusinessJanus kinaseSTAT6 Transcription FactorProto-Oncogene Proteins c-akt
researchProduct

CARCINOMA SHOWING THYMUS-LIKE DIFFERENTIATION (CASTLE). A CASE REPORT

2013

INTRODUTION: Carcinoma showing thymus-like differentiation (CASTLE) is a rare malignant thyroid cancer. We report a case of CASTLE treated with surgery and adjuvant external neck radiation therapy.MATERIALS AND METHODS: We experienced a case of CASTLE in a 63-year-old man, who presented with a neck mass due to enlarged and hard thyroid gland, most notably in the right lobe, without palpable cervical nodes.RESULTS: Total thyroidectomy was performed for both diagnostic and therapeutic purposes. Histologic examination of the specimen showed a "thymus like" thyroid cancer; the tumor, partially circumscribed, lobulated, involved both lobes, and in more points reached the capsule of the organ and…

Settore MED/18 - Chirurgia GeneraleCastle surgery thyroid cancer
researchProduct

Role of prophylactic central neck dissection in cN0-papillary thyroid carcinoma: Results from a high-prevalence area

2016

BACKGROUND: Prophylactic, compartment-oriented central neck dissection (CND) for cN0 papillary thyroid carcinoma (PTC) is not widely practiced. We examined our results with this surgical approach. METHODS: A cohort of 158 patients operated on for the classical variant of PTC at a follow-up of 1-22 years (mean: 6.6) were enrolled. The patients with a preoperative diagnosis of cN0 PTC (group A, 59 patients) underwent total thyroidectomy (TT) + CND. In the patients with incidental postoperative diagnosis of malignancy (group B, 99 patients) a TT alone was performed. RESULTS: Ninety-six T1, 36 T2, 26 T3/T4 PTC patients were enrolled. The overall biochemical/scintigraphic recurrence rate (15 pat…

Settore MED/18 - Chirurgia GeneraleRecurrencePapillaryThyroidectomySurgeryNeck dissectionTherapeuticNeck dissection; Papillary; Recurrence; Therapeutics; Thyroid cancer; Thyroidectomy; SurgeryThyroid cancer
researchProduct

Performance of Contrast-Enhanced Ultrasound in Thyroid Nodules: Review of Current State and Future Perspectives

2021

Simple Summary Ultrasound has been used as baseline imaging for thyroid nodules for decades; nevertheless, no single feature is sensitive or specific enough to exclude or confirm thyroid malignancy. Therefore, clinical practice and research still focus on less invasive diagnostic patterns to reduce unnecessary fine-needle aspiration biopsies or surgery. The main advantage of CEUS is the ability to assess the sequence and intensity of vascular perfusion and hemodynamics in the thyroid nodule, thus providing real-time characterization of nodule features, and considered a valuable new approach in the determination of benign vs. malignant nodules. In addition, contrast agents used in CEUS can h…

Thyroid nodulesCancer Researchmedicine.medical_specialtycontrast-enhanced ultrasound (CEUS)ReviewMalignancyPapillary thyroid cancermedicinethyroid cancerpapillary thyroid cancerFollicular thyroid cancerThyroid cancerRC254-282business.industrythyroid nodulesfollicular thyroid cancerThyroidNeoplasms. Tumors. Oncology. Including cancer and carcinogensNodule (medicine)medicine.diseasemedicine.anatomical_structureOncologycontrast-enhanced ultrasound (CEUS); follicular thyroid cancer; papillary thyroid cancer; thyroid cancer; thyroid nodulesRadiologymedicine.symptombusinessContrast-enhanced ultrasoundCancers
researchProduct

A two miRNA classifier differentiates follicular thyroid carcinomas from follicular thyroid adenomas.

2015

The inherent diagnostic limitations of thyroid fine needle aspiration (FNA), especially in the "indeterminate" category, can be partially overcome by molecular analyses. We aimed at the identification of miRNAs that could be used to improve the discrimination of indeterminate FNAs. miRNA expression profiling was performed for 17 follicular carcinomas (FTCs) and 8 follicular adenomas (FAs). The microarray results underwent cross-comparison using three additional microarray data sets. Candidate miRNAs were validated by qPCR in an independent set of 32 FTCs and 46 FAs. Sixty-eight differentially expressed miRNAs were identified. Thirteen miRNAs could be confirmed by cross comparison. A two-miR…

Thyroid nodulesMaleMicroarrayThyroid Neoplasms/classificationBiologyBioinformaticsClassifierMicroRNAs/biosynthesisBiochemistryFollicular thyroid cancerThyroid carcinomaAdenocarcinoma Follicular/classificationEndocrinologyAdenocarcinoma FollicularDatabases GeneticmedicineHumansRNA NeoplasmThyroid NeoplasmsFollicular thyroid cancerMolecular Biologymedicine.diagnostic_testMicroarray analysis techniquesThyroidmedicine.diseaseGene Expression Regulation NeoplasticMicroRNAsFine-needle aspirationmedicine.anatomical_structureCancer researchFemaleFollicular thyroid adenomaIndeterminateRNA Neoplasm/biosynthesisMolecular and cellular endocrinology
researchProduct